Total Payments
$4,557
2024 Payments
$1,971
Companies
28
Transactions
266
Medicare Patients
1,045
Medicare Billing
$74,543
Payment Breakdown by Category
Food & Beverage$4,550 (99.8%)
Education$7.12 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,550 | 265 | 99.8% |
| Education | $7.12 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $857.54 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $719.22 | 21 | $0 (2024) |
| PFIZER INC. | $716.07 | 43 | $0 (2024) |
| Lilly USA, LLC | $601.74 | 38 | $0 (2024) |
| ABBVIE INC. | $590.73 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $194.64 | 14 | $0 (2022) |
| Abbott Laboratories | $99.03 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $80.98 | 5 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $75.86 | 5 | $0 (2024) |
| Amgen Inc. | $74.12 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,971 | 109 | AstraZeneca Pharmaceuticals LP ($436.14) |
| 2023 | $1,142 | 70 | Novo Nordisk Inc ($253.09) |
| 2022 | $174.78 | 12 | Novo Nordisk Inc ($44.29) |
| 2020 | $145.09 | 11 | PFIZER INC. ($54.15) |
| 2019 | $314.42 | 22 | PFIZER INC. ($68.60) |
| 2018 | $436.31 | 24 | PFIZER INC. ($193.80) |
| 2017 | $373.28 | 18 | AstraZeneca Pharmaceuticals LP ($179.19) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: Medical Device | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $37.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: VACCINES | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.46 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.77 | General |
| 10/09/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Medical Device | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 313 | 410 | $55,981 | $27,794 |
| 2022 | 8 | 241 | 288 | $42,841 | $20,501 |
| 2021 | 9 | 245 | 303 | $42,631 | $14,334 |
| 2020 | 9 | 246 | 332 | $47,798 | $11,915 |
Total Patients
1,045
Total Services
1,333
Medicare Billing
$74,543
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 109 | $21,037 | $8,860 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $14,144 | $8,522 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 82 | $10,660 | $4,958 | 46.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,017 | $2,091 | 52.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $2,756 | $1,867 | 67.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,260 | $822.08 | 65.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 34 | $1,190 | $323.68 | 27.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $494.00 | $144.82 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 16 | $192.00 | $134.40 | 70.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 21 | $231.00 | $71.61 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 78 | $15,054 | $5,918 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $9,152 | $5,628 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 84 | $10,920 | $4,611 | 42.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $3,708 | $1,973 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,332 | $1,508 | 64.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 25 | $1,125 | $699.32 | 62.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $418.00 | $122.81 | 29.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 12 | $132.00 | $41.11 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $6,864 | $4,311 | 62.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 92 | $17,756 | $3,349 | 18.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 11 | 11 | $3,300 | $1,828 | 55.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 59 | $7,670 | $1,789 | 23.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 22 | 22 | $2,332 | $1,436 | 61.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 22 | 22 | $2,200 | $835.56 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,035 | $372.37 | 36.0% |
About Dr. David Hayes, DO
Dr. David Hayes, DO is a Family Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1003103672.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hayes, DO has received a total of $4,557 in payments from pharmaceutical and medical device companies, with $1,971 received in 2024. These payments were reported across 266 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,550).
As a Medicare-enrolled provider, Hayes has provided services to 1,045 Medicare beneficiaries, totaling 1,333 services with total Medicare billing of $74,543. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cincinnati, OH
- Active Since 07/05/2011
- Last Updated 07/11/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003103672
Products in Payments
- AIRSUPRA (Drug) $422.65
- MOUNJARO (Drug) $390.40
- UBRELVY (Drug) $323.44
- Rybelsus (Drug) $287.08
- Ozempic (Drug) $224.56
- JARDIANCE (Drug) $180.61
- NURTEC ODT (Drug) $169.84
- CHANTIX (Drug) $161.82
- BEVESPI AEROSPHERE (Drug) $153.51
- QULIPTA (Drug) $150.28
- VRAYLAR (Drug) $117.01
- EUCRISA (Drug) $114.56
- PAXLOVID (Drug) $96.80
- PREVNAR 20 (Biological) $96.39
- Wegovy (Drug) $85.97
- TOUJEO (Drug) $80.79
- FARXIGA (Drug) $77.91
- QUVIVIQ (Drug) $75.86
- SOLIQUA 100/33 (Biological) $72.32
- FREESTYLE LIBRE 3 (Device) $64.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cincinnati
Michael Heile, Md, MD
Family Medicine — Payments: $382,686
Family Medicine $382,686
Amy Mechley, Md, MD
Family Medicine — Payments: $277,547
Family Medicine $277,547
Paul Nugent, D.o, D.O
Family Medicine — Payments: $159,309
Family Medicine $159,309
Melissa Schroer, Md, MD
Family Medicine — Payments: $147,431
Family Medicine $147,431
Dr. Shayla Pullen, Md, MD
Family Medicine — Payments: $32,310
Family Medicine $32,310
William Cox, Md, MD
Family Medicine — Payments: $24,617
Family Medicine $24,617